Serum Institute Of India

Serum Institute of India Inks Large-Scale Supply Deal For BCG Use In ImmunityBio's Bladder Cancer Combo Therapy
Raw Material Shortage Holding Up Novavax's COVID-19 Shot Manufacturing, Says Serum Institute
US To Send COVID-19 Vaccine Raw Materials 'Urgently Required' To Help India Tackle Surge In Infections
Raw Material Shortage Holding Up Novavax's COVID-19 Shot Manufacturing, Says Serum Institute
US To Send COVID-19 Vaccine Raw Materials 'Urgently Required' To Help India Tackle Surge In Infections
Serum Institute Nears $400M Funding From Indian Government To Boost COVID-19 Vaccine Manufacturing Capacity
EU Turns To India To Fill AstraZeneca Vaccine Supply Gap: Reuters

Serum Institute Of India Recent News

Tata In Partnership Talks With Moderna To Launch COVID-19 Vaccine In India: Report
Indian conglomerate Tata Sons are in discussion with Moderna Inc (NASDAQ: MRNA) for a partnership with its healthcare unit Tata Medical & Diagnostics, the 
Fire Breaks Out At World's Largest Vaccine Manufacturer Site In India, Vaccine Production Not Hit: Report
A major fire broke out at an under-construction building in the Serum Institute of India (SII) in the city of Pune, 
AstraZeneca Follows Pfizer In Seeking India Emergency Use Approval For COVID-19 Vaccine
AstraZeneca Plc’s  (NASDAQ: AZN) partner, the Serum Institute of India, applied for emergency use authorization of the former's COVID-19 vaccine candidate on Sunday, as per
100M Doses Of AstraZeneca COVID-19 Vaccine Prepared For Inoculation Drive In India Next Month, Partner Says
A hundred million doses of AstraZeneca Plc’s (NASDAQ: AZN) COVID-19 vaccine would be ready for distribution in India by December and an inoculation drive could begin the same month, Bloomberg
AstraZeneca Gets India Go-Ahead To Resume COVID-19 Vaccine Trials, US Nod Awaited
AstraZeneca plc (NYSE: AZN) COVID-19 vaccine clinical trial is set to resume in India after local partner Serum Institute of India received the go-ahead from Indian regulators, Reuters reported Wednesday.
Novavax Inks Deal With India's Serum Institute To Make Coronavirus Vaccine Available In Low, Middle Income Countries
Novavax, Inc (NASDAQ: NVAX) disclosed Wednesday it had entered into an agreement with the Serum Institute of India Private Limited for development, distribution, and commercialization of its COVID-19 vaccine in several countries.